Abstract Body

In resource limited settings, the use of Dried Blood Spots (DBS) for HIV viral diagnosis and monitoring has become a necessity for improved patient management. In this study, we evaluated the performance of the Abbott ARCHITECT HIV Ag/Ab Combo assay using DBS samples.

Whole blood (WB) from matched pairs of HIV infected plasma/WB samples was spotted on the Whatman 903 cards, dried overnight, eluted, and tested with HIV Ag/Ab Combo assay. Reproducibility of the test results was assessed using triplicates of the 12mm and 6mm DBS from four HIV samples. DBS stability was evaluated on samples stored for up to 14 days at -20oC, room temperature (RT) and +37oC. To evaluate sensitivity, DBS from 500 HIV infected subjects were tested and compared to matched plasma. Reproducibility of the DBS results with low plasma signal to cutoff ratio (S/CO) levels was evaluated by testing 12 samples in replicates.

DBS results were reproducible in both 12mm (CV 1-8.3%) and 6-mm (CV 1.9-5.8%). S/CO from 12mm DBS were up to 2 fold higher compared to 6mm. DBS remained HIV reactive after 14 days storage. We observed <7% drop in S/CO at -20oC, <12% at RT and ≤20% at +37oC on day 14. Of 500 DBS samples with HIV Ag/Ab reactive matched plasma, 471 (94.2%) were reactive and 29 (5.8%) nonreactive. All samples with a plasma S/CO>23 (n=465) were reactive by DBS. Of the 35 samples with S/CO<23 only 6 (17%) DBS were reactive. DBS replicates for samples with 7-30 S/CO in plasma were concordant for 11 samples and discordant for only one sample. For 2 samples with 7-10 S/CO in plasma all replicates were nonreactive (n=40, CV 24.7%). Of 9 samples with 11-23 S/CO in plasma, 4 were reactive in all replicates (n=76, CV 2.52-19.97%) and 5 were nonreactive in 78 of 80 (97.5%) replicates (CV 4.99-172.6%); one sample with plasma S/CO>23 was reactive in all replicates (n=20, CV 4.44%).The detection rate for samples with plasma S/CO range of 7-10, 11-23 and >23 was estimated as 0%, 52% and 100% respectively.

The results indicate that Whatman 903 DBS is a suitable specimen type for the ARCHITECT HIV Ag/Ab Combo assay. The assay reliably detects HIV-1 p24 antigen/ anti-HIV-1/-2 antibodies in DBS with corresponding plasma S/CO>23. According to the Abbott Global Surveillance Database where samples were collected all over the world and characterized over 15 years, 95.4% of HIV-infected specimens have HIV Ag/Ab results of S/CO>23 in plasma or serum.